UNDERWRITING AGREEMENT between Intensity Therapeutics, Inc. and Roth Capital Partners, LLC as Representative of the Several Underwriters Intensity Therapeutics, Inc.Underwriting Agreement • September 20th, 2022 • Intensity Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 20th, 2022 Company Industry JurisdictionThe undersigned, Intensity Therapeutics, Inc., a corporation formed under the laws of the State of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Intensity Therapeutics, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with Roth Capital Partners, LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
UNDERWRITER COMMON STOCK PURCHASE WARRANT Intensity Therapeutics, Inc.Underwriter Common Stock Purchase Warrant • September 20th, 2022 • Intensity Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 20th, 2022 Company Industry JurisdictionTHIS UNDERWRITER COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _____1 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _____2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Intensity Therapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to the Underwriting Agreement.